Povidyle M Cream contains Metronidazole 1% w/w, an anti-protozoal and antibacterial agent, combined with Povidone Iodine 5% w/w, a broad-spectrum antiseptic. This dual-action formulation is ideal for treating infected wounds, acne with secondary bacterial infection, minor cuts, abrasions, and protozoal skin infections.
The cream works by inhibiting microbial growth, reducing inflammation, and promoting faster healing. Metronidazole targets anaerobic bacteria and protozoa, while Povidone Iodine provides broad-spectrum antimicrobial protection, making it suitable for both dermatological and first-aid applications.
Povidyle M Cream belongs to the dermatology, antiseptic, and anti-infective segment, making it a frequently recommended product by dermatologists, surgeons, and general practitioners.
For PCD pharma franchise partners, wholesalers, and exporters, Povidyle M Cream offers a profitable opportunity due to its continuous demand in dermatology and hospital-care markets. It is available for bulk supply, monopoly-based PCD franchise, third-party manufacturing, institutional distribution, and export, ensuring strong business potential and sustained market growth.